Diverticular disease: the Australian general practice guide

Understanding diverticular disease

Diverticular disease is one of the most common gastrointestinal conditions seen in Australian general practice. Diverticula — small mucosal pouches that herniate through the colonic wall at points where small arteries penetrate the muscle layer — become more prevalent with age, affecting roughly 10% of Australians by age 40, around 60% by age 70, and approximately 70% by age 80. Despite this high prevalence, the majority of people with diverticulosis remain asymptomatic throughout their lives.

The clinical spectrum spans four presentations. Diverticulosis is the incidental finding of diverticula without symptoms, most often discovered on colonoscopy or CT performed for another reason. Symptomatic uncomplicated diverticular disease (SUDD) describes chronic or recurrent lower abdominal discomfort without overt inflammation — a diagnosis of exclusion that overlaps significantly with irritable bowel syndrome. Acute diverticulitis is inflammation of one or more diverticula and accounts for the majority of GP attendances for diverticular disease: roughly 75% of episodes are uncomplicated and 25% complicated (abscess, perforation, fistula, obstruction). Diverticular bleeding is a separate phenomenon — painless lower gastrointestinal haemorrhage from arterial rupture at the diverticular neck.

In Australian and Western populations, diverticula predominate in the sigmoid and descending colon. Asian populations show right-sided predominance, which has clinical implications when considering differential diagnoses.

A. Core clinical — the AU general-practice framework

History

The first task in general practice is identifying where on the spectrum the patient sits.

• Pain characteristics — location (left iliac fossa is typical for sigmoid diverticulitis; right iliac fossa raises right-sided diverticulitis or appendicitis), onset, severity, radiation to back or groin
• Systemic features — fever and systemic illness suggest active inflammation; SIRS criteria (heart rate above 90, respiratory rate above 20, temperature above 38°C or below 36°C, white cell count above 12 or below 4 × 10⁹/L) indicate more serious disease
• Bowel habit — constipation is more common than diarrhoea in acute diverticulitis; diarrhoea raises inflammatory bowel disease as a differential
• Rectal bleeding — painless, often substantial rectal bleeding without abdominal pain suggests diverticular haemorrhage rather than diverticulitis
• Chronicity and pattern — chronic or recurrent lower abdominal pain without fever or raised inflammatory markers, with bloating and altered bowel habit, fits SUDD
• Medication review — NSAID use (substantially increases perforation risk), opioids (constipation, perforation risk), corticosteroids
• Risk factors — smoking, obesity, sedentary lifestyle, low dietary fibre intake
• Prior episodes — recurrence history, prior imaging or colonoscopy results
• Immunocompromise — biologics, chemotherapy, corticosteroids, HIV, transplant; atypical presentation is common

Examination

• Localised left iliac fossa tenderness on palpation is the typical finding in uncomplicated sigmoid diverticulitis
• Peritonism (guarding, rebound tenderness, rigidity) indicates complicated disease — arrange urgent imaging and assess for admission
• Document vital signs and calculate SIRS criteria to guide antibiotic and admission decisions
• Rectal examination if lower gastrointestinal bleeding is part of the presentation

Investigation

Acute diverticulitis:

CT abdomen and pelvis with contrast is the gold standard — sensitivity and specificity approximately 95% for acute diverticulitis. It confirms the diagnosis, defines the Hinchey stage (from localised pericolic inflammation through abscess to perforation with peritonitis), and guides the outpatient versus inpatient decision (NICE NG147). Request CT for all first presentations and whenever outpatient management is planned.

Blood tests: FBC (white cell count), CRP (often markedly elevated), U&E, LFTs, blood cultures if septic. Urinalysis: exclude UTI and identify colovesical fistula (pneumaturia, faecaluria). β-hCG in women of reproductive age.

Critically: do not perform colonoscopy during the acute phase — the risk of perforation into an already inflamed segment is substantially elevated.

Interval assessment:

Colonoscopy four to eight weeks post-acute episode is recommended after a first episode to exclude an underlying colorectal malignancy (yield approximately 3%). CT colonography is an acceptable alternative when colonoscopy is contraindicated or the patient declines. GESA consensus supports this as standard care.

Management

Uncomplicated diverticulitis — outpatient pathway:

Selected patients can be managed safely at home. Outpatient criteria: clinically stable, tolerating oral fluids, no peritonism, no SIRS features, no significant immunocompromise, adequate social supports, clear return precautions provided.

• Bowel rest and clear fluids initially, advancing to soft then normal diet over several days as symptoms settle
• Paracetamol 1 g up to four times daily for analgesia — avoid NSAIDs (associated with substantially increased perforation risk per eTG and RACGP guidance)
• Antibiotics — use selectively (see Section B for trial evidence): indications include SIRS/sepsis features, immunocompromise, significant comorbidity, complicated disease, pregnancy, or frail older adults with multiple comorbidities
• When antibiotics are indicated: amoxicillin/clavulanic acid 875/125 mg twice daily for 7 days; OR metronidazole 400 mg three times daily plus ciprofloxacin 500 mg twice daily for 7 days (covering anaerobes and gram-negatives per eTG)
• Review at 48–72 hours; provide written return precautions: worsening pain, fever, inability to tolerate fluids, any new peritonism

Complicated diverticulitis and inpatient management:

Indications for admission: sepsis, complicated disease (Hinchey II–IV abscess, perforation, fistula, obstruction), failure of 48–72 hours outpatient management, inability to tolerate oral intake.

IV antibiotics per eTG: piperacillin/tazobactam OR ceftriaxone plus metronidazole. Bowel rest and IV fluid resuscitation. Image-guided abscess drainage (interventional radiology) for abscesses ≥3–4 cm — reduces need for emergency surgery. Surgical management for perforation with peritonitis, obstruction, fistula not responding to conservative treatment, or large abscess not amenable to drainage. The Hartmann procedure (sigmoid resection with end colostomy) is used for urgent unstable patients; primary anastomosis (± defunctioning ileostomy) is an option for selected stable patients.

Diverticular bleeding:

Resuscitate with IV access and fluid support; transfuse as required. CT angiography identifies active bleeding at rates ≥0.5 mL/min and guides embolisation. Colonoscopy provides both diagnosis and therapy (haemostatic clipping, injection). Interventional radiology embolisation is effective for active arterial bleeding. Surgery is reserved for refractory severe haemorrhage.

B. The evidence that changed practice

Antibiotics for uncomplicated diverticulitis

The AVOD trial (Chabok et al., BJS 2012) randomised 623 patients with CT-confirmed uncomplicated acute diverticulitis to antibiotics versus no antibiotics. No significant difference was found in complication rates, need for surgery, or recovery time. This was the first large randomised trial to challenge the routine antibiotic paradigm.

The DIABOLO trial (Daniels et al., BJS 2017) replicated these findings in 528 patients: no significant difference in time to recovery, complication rate, or readmission at six months. The antibiotic group had a marginally longer hospital stay.

Both trials excluded patients with SIRS criteria, immunocompromise, significant comorbidity, or complicated disease — these groups still require antibiotics. For the selected uncomplicated patient without these features, withholding antibiotics is supported by high-quality randomised evidence and NICE NG147.

Nuts, seeds, and the diet myth

Strate et al. (JAMA 2008) followed a prospective cohort of over 47,000 men and found no association between consumption of nuts, seeds, corn, or popcorn and incident diverticulitis or diverticular bleeding over an 18-year follow-up. This definitively debunked a dietary restriction that had been advised, without evidence, for decades. Patients should be actively reassured that nuts, seeds, and a varied high-fibre diet are encouraged.

Selective versus automatic elective surgery

Multiple observational studies and position statements from ACPGBI, EAES, and NICE NG147 have moved away from automatic sigmoid resection after two uncomplicated episodes. The complication risk of recurrent uncomplicated diverticulitis does not justify routine elective surgery. A selective approach — shared decision-making with a colorectal surgeon, incorporating symptom frequency, quality-of-life impact, complication history, immunocompromise, and individual surgical risk — is current best practice.

C. Dietary and lifestyle management

Long-term prevention of diverticulitis recurrence and progression rests primarily on modifiable lifestyle factors. GESA and RACGP resources align on these recommendations.

Dietary fibre: Aim for at least 30 g dietary fibre per day. Both soluble fibre (psyllium, oats, legumes, fruit) and insoluble fibre (wholegrains, vegetables) are beneficial; soluble fibre is gentler during recovery from an acute episode. A Mediterranean-pattern diet provides a practical, patient-friendly framework aligned with high-fibre principles, and has emerging evidence specifically in diverticular disease.

Physical activity: Regular aerobic exercise — at least 150 minutes per week — reduces incident diverticulitis risk and supports healthy bowel motility. Resistance training provides complementary general health benefit.

Smoking cessation: Smoking increases relative risk of diverticulitis by approximately 1.4-fold and is associated with more complications. Cessation support should be offered at every consultation — see Quitline and NPS MedicineWise smoking-cessation resources.

Weight management: Obesity is an independent risk factor for incident diverticulitis and complications. Address as part of the chronic disease management approach.

Avoiding NSAIDs: NSAIDs substantially increase perforation risk in diverticular disease. Paracetamol is the default analgesic for patients with known diverticular disease. If NSAIDs are clinically necessary, use at the lowest effective dose for the shortest duration.

Avoiding opioids where possible: Opioids worsen constipation and increase perforation risk. They are appropriate short-term for severe pain but should be avoided as long-term analgesia in diverticular disease.

Probiotics, rifaximin, and mesalamine have been studied for SUDD and recurrent disease; evidence remains mixed and they are not standard practice in Australia. These are specialist decisions for refractory SUDD.

D. Australian operations

MBS items

• Items 23/36/44 — GP consultations (Level B/C/D); item 44 appropriate for complex acute presentations
• Item 56401 — CT abdomen and pelvis with contrast (acute presentation); item 56501 — CT colonography (interval, when colonoscopy contraindicated)
• Items 32084/32087/32090 — colonoscopy (interval, diagnostic, therapeutic)
• Item 73807 — pathology bundle (FBC, CRP, U&E, LFTs)
• Item 30443 — image-guided abscess drainage (interventional radiology)
• Items 32200/32201 — sigmoid colectomy (elective); item 35614 — Hartmann’s procedure (emergency)
• Items 965/967 — GP Chronic Disease Management Plan for recurrent or chronic diverticular disease with comorbidity
• Item 715 — ATSI Health Assessment; item 707 — 75+ Health Assessment (both provide structured opportunities to address bowel health, colonoscopy, and medication review)

PBS prescribing

• Amoxicillin/clavulanic acid (Augmentin Duo Forte) — General Schedule
• Metronidazole, ciprofloxacin — General Schedule
• Paracetamol — General Schedule
• Mesalamine (Salofalk, Pentasa) — Authority Required for inflammatory bowel disease; off-label for diverticular disease (specialist context only)

Referral pathways

Gastroenterologist: colonoscopy four to eight weeks post-acute episode; chronic or refractory SUDD not responding to dietary and lifestyle measures; diagnostic uncertainty (IBD, malignancy).

Colorectal surgeon: recurrent complicated disease, fistula (colovesical — pneumaturia, faecaluria; colovaginal — vaginal faeces), stricture, elective resection assessment, suspected underlying malignancy not suitable for endoscopic management.

Interventional radiology: abscess drainage ≥3–4 cm; diverticular bleeding embolisation.

Emergency department: sepsis, peritonism, suspected perforation or obstruction, inability to manage safely as an outpatient, severe diverticular bleeding requiring resuscitation.

AU patient resources: HealthDirect — Diverticulitis, Better Health Channel — Diverticular disease, Bowel Cancer Australia for bowel health and colonoscopy education.

E. Special populations

Older adults: Diverticulosis is near-universal in adults over 70. Clinical presentations may be less dramatic — reduced fever and less severe pain despite significant disease, due to blunted inflammatory response and polypharmacy (particularly corticosteroids). Maintain a lower threshold for CT imaging, admission, and specialist review in frail older adults. NSAIDs carry additional renal and gastrointestinal risk in this population. Chronic care plans (MBS items 721/723 or the GPMP 721) support coordinated management of recurrent disease in complex older patients.

Immunocompromised patients: Immunosuppression — corticosteroids, biologics, chemotherapy, transplant immunosuppressants, or untreated HIV — substantially blunts the inflammatory response, meaning serious complicated diverticulitis may present with minimal pain and low-grade fever. Complications are more frequent and more severe. Lower threshold for CT, admission, and antibiotic use. Elective sigmoid resection is considered at a lower episode-number threshold in immunocompromised patients with recurrent disease, in partnership with the patient’s immunology or transplant team.

Young patients (under 50 years): Acute diverticulitis in younger patients, particularly men under 40, may have a more aggressive natural history with higher recurrence rates. In young Asian patients, right-sided diverticulitis is common and mimics appendicitis — CT clarifies the distinction. Some surgical guidelines recommend earlier consideration of elective resection in younger patients with complicated first episodes or frequent recurrences, but shared decision-making remains central.

Pregnancy: Diverticulitis in pregnancy is rare but potentially serious. CT is generally used for diagnosis given the urgency of the clinical situation, balancing radiation exposure against diagnostic necessity. Surgical management follows standard principles adapted to the stage of pregnancy, with specialist obstetric and surgical co-management.

When to escalate

Escalate urgently to the emergency department for peritonism (guarding, rebound tenderness, rigidity), SIRS or sepsis, suspected perforation or bowel obstruction, inability to tolerate oral fluids at home, or severe lower gastrointestinal haemorrhage requiring resuscitation.

Refer to colorectal surgery for Hinchey II–IV disease (pelvic abscess, purulent peritonitis, faecal peritonitis), obstruction, fistula, or failure of 48–72 hours of outpatient management. Elective referral is appropriate for recurrent disease (two or more symptomatic episodes), persistent SUDD refractory to dietary and lifestyle measures, and any clinical suspicion of underlying malignancy not yet investigated.

Refer to gastroenterology for interval colonoscopy post-acute episode, diagnostic uncertainty between diverticular disease and inflammatory bowel disease, and refractory SUDD.

What to include in the referral: CT images and report, trend in inflammatory markers, colonoscopy history, episode count and timeline, current medication list (particularly NSAIDs, anticoagulants, immunosuppressants), and clinical stability at the time of referral.

What this article is and is not

This is general health information drawn from current Australian and international guidelines — Therapeutic Guidelines (eTG), GESA consensus, RACGP resources, and NICE NG147 — as well as the DIABOLO and AVOD randomised trials. It is not personal medical advice and does not create a doctor–patient relationship. All decisions about investigation, antibiotic use, admission, and surgery are made with the treating clinician based on the individual clinical presentation.

For patient-friendly information: HealthDirect — Diverticulitis and Better Health Channel — Diverticular disease.

For acute abdominal emergency: call 000 or attend your nearest emergency department immediately.

---

Sources cited

1. Therapeutic Guidelines (eTG) — Gastrointestinal
2. GESA — Diverticular disease management consensus
3. RACGP — Diverticular disease in Australian Family Physician
4. NICE NG147 — Diverticular disease: diagnosis and management
5. DIABOLO trial — Daniels et al. (BJS 2017)
6. AVOD trial — Chabok et al. (BJS 2012)
7. Strate et al. — Nuts, seeds, corn, popcorn and diverticular disease (JAMA 2008)
8. ACG 2021 — Clinical Guideline: Acute Diverticulitis
9. NPS MedicineWise — Gastrointestinal conditions
10. HealthDirect — Diverticulitis
11. Better Health Channel — Diverticular disease